IMDX – insight molecular diagnostics inc. (US:NASDAQ)
Stock Stats
News
Oncocyte (NASDAQ:IMDX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Oncocyte (NASDAQ:IMDX) is now covered by analysts at Weiss Ratings. They set a "sell (d-)" rating on the stock.
Oncocyte (NASDAQ:IMDX) was upgraded by analysts at Wall Street Zen t
Insight Molecular Diagnostics: GraftAssureDX FDA Submission Warrants Hold Rating [Seeking Alpha]
This Biotech Stock Is Up 158% in a Year. What's Driving It Higher? [Yahoo! Finance]
Form 10-Q Insight Molecular Diagno For: Sep 30
Form 8-K Insight Molecular Diagno For: Nov 10
Form 4 Insight Molecular Diagno For: Oct 31 Filed by: James Andrea S.
Form 8-K Insight Molecular Diagno For: Sep 28
Form 4 Insight Molecular Diagno For: Sep 28 Filed by: Liu James Yang
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.